446 related articles for article (PubMed ID: 25129443)
21. Alpha-L-fucosidase as a tumour marker of hepatocellular carcinoma.
Fawzy Montaser M; Amin Sakr M; Omar Khalifa M
Arab J Gastroenterol; 2012 Mar; 13(1):9-13. PubMed ID: 22560818
[TBL] [Abstract][Full Text] [Related]
22. Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma.
Chen K; Zhang H; Zhang LN; Ju SQ; Qi J; Huang DF; Li F; Wei Q; Zhang J
World J Gastroenterol; 2013 May; 19(20):3143-9. PubMed ID: 23716996
[TBL] [Abstract][Full Text] [Related]
23. Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma.
Pontisso P; Quarta S; Caberlotto C; Beneduce L; Marino M; Bernardinello E; Tono N; Fassina G; Cavalletto L; Gatta A; Chemello L
Int J Cancer; 2006 Aug; 119(4):735-40. PubMed ID: 16550605
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis.
Gan Y; Liang Q; Song X
Tumour Biol; 2014 May; 35(5):3953-60. PubMed ID: 24395655
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma.
Jingting J; Changping W; Ning X; yibei Z; Jun W; Mei J; Bin X; Peter NE; Xueguan Z
J Clin Lab Anal; 2009; 23(4):213-8. PubMed ID: 19623644
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous determination of alpha-fetoprotein immune complexes and alpha-fetoprotein concentration in hepatocellular carcinoma using dual-label time-resolved immunofluorometric assays.
Sheng SL; Wang Q; Huang G; Yu B; Qin WX
J Clin Lab Anal; 2009; 23(3):179-85. PubMed ID: 19455631
[TBL] [Abstract][Full Text] [Related]
27. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study.
Biasiolo A; Trotta E; Fasolato S; Ruvoletto M; Martini A; Gallotta A; Fassina G; Angeli P; Gatta A; Pontisso P
Dig Liver Dis; 2016 Feb; 48(2):197-202. PubMed ID: 26614642
[TBL] [Abstract][Full Text] [Related]
28. Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma.
Jiang J; Wu C; Shen Y; Xu B; Zheng X; Li X; Xu N
Anticancer Res; 2011 Feb; 31(2):687-91. PubMed ID: 21378357
[TBL] [Abstract][Full Text] [Related]
29. SCCA antigen combined with alpha-fetoprotein as serologic markers of HCC.
Giannelli G; Marinosci F; Trerotoli P; Volpe A; Quaranta M; Dentico P; Antonaci S
Int J Cancer; 2005 Nov; 117(3):506-9. PubMed ID: 15906357
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
[TBL] [Abstract][Full Text] [Related]
31. Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes.
Beneduce L; Castaldi F; Marino M; Tono N; Gatta A; Pontisso P; Fassina G
Int J Biol Markers; 2004; 19(2):155-9. PubMed ID: 15255549
[TBL] [Abstract][Full Text] [Related]
32. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
[TBL] [Abstract][Full Text] [Related]
33. IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease.
Biasiolo A; Tono N; Ruvoletto M; Quarta S; Turato C; Villano G; Beneduce L; Fassina G; Merkel C; Gatta A; Pontisso P
PLoS One; 2012; 7(7):e40658. PubMed ID: 22808225
[TBL] [Abstract][Full Text] [Related]
34. Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.
Reichl P; Fang M; Starlinger P; Staufer K; Nenutil R; Muller P; Greplova K; Valik D; Dooley S; Brostjan C; Gruenberger T; Shen J; Man K; Trauner M; Yu J; Gao CF; Mikulits W
Int J Cancer; 2015 Jul; 137(2):385-394. PubMed ID: 25529751
[TBL] [Abstract][Full Text] [Related]
35. [A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma].
Shen W; Shen DM
Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):397-9, 442-3. PubMed ID: 2480210
[TBL] [Abstract][Full Text] [Related]
36. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
Feng H; Li B; Li Z; Wei Q; Ren L
BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
[TBL] [Abstract][Full Text] [Related]
37. Enhanced detection of hepatocellular carcinoma.
el-Houseini ME; Mohammed MS; Elshemey WM; Hussein TD; Desouky OS; Elsayed AA
Cancer Control; 2005 Oct; 12(4):248-53. PubMed ID: 16258497
[TBL] [Abstract][Full Text] [Related]
38. Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Ali LH; Higazi AM; Moness HM; Farag NM; Saad ZM; Moukareb HA; Soliman W; El Sagheer G; Abd El Hamid SR; Abdl Hamid H
Clin Exp Gastroenterol; 2019; 12():51-66. PubMed ID: 30774409
[TBL] [Abstract][Full Text] [Related]
39. Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC.
Trerotoli P; Fransvea E; Angelotti U; Antonaci G; Lupo L; Mazzocca A; Mangia A; Antonaci S; Giannelli G
Mol Cancer; 2009 May; 8():29. PubMed ID: 19473531
[TBL] [Abstract][Full Text] [Related]
40. Clinical utility of alpha fetoprotein and HCCR-1, alone or in combination, in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Jirun P; Zhang G; Kim HK; Ha SA; Zhongtian J; Shishi Q; Zhuqingqing C; Lei G; Yoo J; Kim S; Park YG; Wang J; Yang Y; Xu Z; Huang Z; Lee YK; Song EY; Kim JW
Dis Markers; 2011; 30(6):307-15. PubMed ID: 21725159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]